ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

18,062Medicare Part D Prescriptions Filled, Including Refills

Rank: 143 out of 5176

$1.29M Total Retail Price of All Prescriptions

Rank: 146 out of 5176

440 Patients Receiving at Least One Drug in Part D
90%Patients 65 Years and Older
93% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 440 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

10% of this provider’s 440 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 16,379 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

26% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$71 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

41 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 831 771 1 3
CITALOPRAM HBR 623 584 2 31
FUROSEMIDE 620 604 3 8
METOPROLOL TARTRATE 579 497 4 6
LEVOTHYROXINE SODIUM 457 418 5 4
DONEPEZIL HCL 439 437 6 28
SIMVASTATIN 410 399 7 1
AMLODIPINE BESYLATE 395 365 8 2
MIRTAZAPINE 395 388 8 45
GABAPENTIN 384 334 10 21
TRAZODONE HCL 381 346 11 71
LISINOPRIL 369 351 12 5
NAMENDA 308 308 13 47
DIVALPROEX SODIUM 276 249 14 104
NOVOLOG 262 231 15 168
LANTUS 256 209 16 66
METOPROLOL SUCCINATE 245 234 17 11
POLYETHYLENE GLYCOL 3350 241 234 18 74
TRAMADOL HCL 233 224 19 40
POTASSIUM CHLORIDE 228 226 20 34
WARFARIN SODIUM 200 196 21 13
OLANZAPINE 185 130 22 140
HYDROCODONE-ACETAMINOPHEN 173 161 S3 23 27
SERTRALINE HCL 168 165 24 30
ATORVASTATIN CALCIUM 163 151 25 9
QUETIAPINE FUMARATE 161 140 26 75
ESCITALOPRAM OXALATE 158 141 27 89
EXELON 148 148 28 162
ATENOLOL 145 138 29 12
LEVETIRACETAM 142 90 30 92
PRAVASTATIN SODIUM 141 110 31 23
TAMSULOSIN HCL 140 132 32 20
LIDODERM 135 121 33 59
JANTOVEN 130 87 34 106
IPRATROPIUM-ALBUTEROL 122 120 35 138
HYDROCHLOROTHIAZIDE 116 100 36 10
LEVOFLOXACIN 114 107 37 109
CYMBALTA 113 95 38 90
NYSTOP 112 111 39 283
CRESTOR 108 66 40 15
NYSTATIN-TRIAMCINOLONE 103 96 41 142
CARVEDILOL 102 102 42 24
DIOVAN 102 92 42 19
RISPERIDONE 101 76 44 78
TRIAMCINOLONE ACETONIDE 98 52 45 125
CARBIDOPA-LEVODOPA 98 98 45 98
PREDNISONE 94 75 47 52
LITHIUM CARBONATE 87 74 48 393
GLIPIZIDE 86 86 49 63
HYDRALAZINE HCL 85 85 50 73
LOSARTAN POTASSIUM 85 85 50 14
DIGOXIN 84 84 52 56
ADVAIR DISKUS 83 70 53 32
SANTYL 82 39 54 124
FINASTERIDE 81 81 55 69
TOPIRAMATE 80 57 56 314
AZITHROMYCIN 79 75 57 42
ALENDRONATE SODIUM 78 78 58 18
PAROXETINE HCL 76 69 59 93
ZETIA 75 65 60 68
MORPHINE SULFATE 75 72 S2 60 359
CEPHALEXIN 74 66 62 189
METFORMIN HCL 74 65 62 7
TRAVATAN Z 71 71 64 234
FAMOTIDINE 69 69 65 58
FLUTICASONE PROPIONATE 69 64 65 38
IBUPROFEN 66 51 67 72
CLOPIDOGREL 65 65 68 26
TRAMADOL HCL-ACETAMINOPHEN 64 64 69 116
KLOR-CON M20 63 63 70 129
LAMOTRIGINE 63 53 70 289
SPIRIVA 62 55 72 54
FENTANYL 61 60 S2 73 172
ISOSORBIDE DINITRATE 61 61 73 288
AMOX TR-POTASSIUM CLAVULANATE 59 55 75 141
ALBUTEROL SULFATE 57 55 76 99
JANUVIA 56 56 77 25
KLOR-CON M10 54 52 78 248
SEROQUEL 52 44 79 166
BUDESONIDE 51 51 80 380
NORTRIPTYLINE HCL 50 49 81 311
ERYTHROMYCIN 50 49 81 482
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.